Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric R. Olson currently holds 6,661 shares of Syros Pharmaceuticals, Inc. (SYRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric R. Olson has been a net seller of SYRS stock. They have purchased $0 and sold $619.0K worth of shares.
Eric R. Olson's most recent insider trade was on Jul 17, 2023, when they sold 689 shares at $3.50 per share.
Eric R. Olson serves as Executive at Syros Pharmaceuticals, Inc. (SYRS). They have executed 19 insider transactions totaling $619.0K over their tenure at the company.
Eric R. Olson holds the position of Executive at Syros Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Eric R. Olson has shown a selling trading pattern, with $0 in total purchases and $619.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Eric R. Olson was on Jul 25, 2017, when they sold $273.1K worth of SYRS shares. This transaction involved 12,500 shares at $21.85 per share.
Eric R. Olson currently owns 6,661 shares of Syros Pharmaceuticals, Inc. (SYRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric R. Olson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric R. Olson has 19 Form 4 filings on record as an insider at Syros Pharmaceuticals, Inc..
Set alerts for Eric R. Olson and 40,000+ other insiders.